S

Active Director Director DIN 08771729
DIN 08771729 First appointment Jun 2020 Primary industry Home Appliances
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value •••• Premium profile

About Shalu

Data last updated:

Shalu is a Director at Hermes Therapeutics Private Limited (since 2020). The company operates in Home Appliances. Hermes Therapeutics Private Limited reported revenue of ₹60.8 Lakh (FY 2024).

DIN 08771729
Primary Designation Director
Industry Home Appliances
First Appointment 25 Jun 2020
Oldest Company Age 6 yrs
Largest company Hermes Therapeutics Private Limited · ₹60.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hermes Therapeutics Private Limited U51397RJ2020PTC069239
Director25 Jun 20202020₹60.8 Lakh (FY 2024)Active

Board colleagues of Shalu

NameDINCompanyDesignation
Gunjan Ranga08771728Hermes Therapeutics Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hermes Therapeutics Private Limited
Premium access

Shareholding and investment profile for Shalu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shalu

Shalu currently holds 1 directorship: Hermes Therapeutics Private Limited (Director, since 25 Jun 2020, revenue ₹60.8 Lakh (FY 2024)).

Shalu was first appointed on 25 Jun 2020 as Director at Hermes Therapeutics Private Limited.

The current boards of Shalu's companies include Gunjan Ranga (Hermes Therapeutics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available